Sakar Healthcare

Sakar Healthcare EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Sakar Healthcare (SAKAR.NS) as of Nov 5, 2026 is 96.79. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 620.84 — a change of -84.41% (lower).

EV/FCF

96.79

YoY

-84.41%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Sakar Healthcare is 2026 96.79 . EV/FCF (Enterprise Value to Free Cash Flow) of Sakar Healthcare was 2025 620.84 . It decreases by -84.41% lower compared to the previous year.

The Sakar Healthcare EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
-176.22 INR
Jan 1, 2020
-290.21 INR
Jan 1, 2021
-50.26 INR
Jan 1, 2022
-17.74 INR
Jan 1, 2023
-24.04 INR
Jan 1, 2024
-31.07 INR
Jan 1, 2025
620.84 INR
Jan 1, 2026
96.79 INR
The Sakar Healthcare EV/FCF history
YEAREV/FCFYoY
96.79-84.41%
620.84-2,098.22%
-31.07+29.23%
-24.04+35.49%
-17.74-64.70%
-50.26-82.68%
-290.21+64.68%
-176.22-39.09%
-289.33-100.00%
-7.89 M-141.15%
19.18 M+6.49 M%
295.76+66.61%
177.51—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sakar Healthcare Stock analysis

What does Sakar Healthcare do? Sakar Healthcare Ltd. manufactures pharmaceutical products including liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectables (SVP) in ampoules and vials, lyophilized injections, and oral solid dosages. The company operates as a contract development and manufacturing organization (CDMO) providing these products under brand names such as Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin - Oral Solid, and Lyophilised Injections (In Vials). Sakar Healthcare serves markets in 14 countries including Uganda, Kenya, Yemen, Ethiopia, Congo, Zimbabwe, Nigeria, Malawi, Philippines, Peru, Vietnam, and Cote D’Ivoire with approximately 321 product registrations. The company generates revenue through the sale of these pharmaceutical products to healthcare providers and distributors in these regions. The firm’s manufacturing unit is accredited by regulatory authorities in 14 countries, which enables it to produce and distribute products across these markets. Sakar Healthcare’s product portfolio includes liquid injectables (SVP) in ampoules and vials, dry powder injections, and oral solid dosages, which are sold to healthcare facilities and pharmacies. The company’s contracts with clients in the pharmaceutical sector involve developing and manufacturing products according to their specifications, with the firm’s focus on cephalosporin-based medications and liquid formulations. Sakar Healthcare Ltd. focuses on providing contract manufacturing services for pharmaceutical products, with a strong emphasis on cephalosporin formulations and liquid-based medications. The company’s products are registered in 321 product registrations across various countries, supporting its operations in 14 regulatory markets. Revenue is derived from the production and sale of these registered products to healthcare providers and distributors in the regions where it holds regulatory accreditation. Sakar Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sakar Healthcare stock

EV/FCF (Enterprise Value to Free Cash Flow) of Sakar Healthcare is 96.79 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Sakar Healthcare changed from 620.84 to 96.79, representing a -84.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Sakar Healthcare since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Sakar Healthcare with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Sakar Healthcare

All Key Metrics — Sakar Healthcare